These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25410047)

  • 1. When compliance is an issue-how to enhance statin adherence and address adverse effects.
    Birtcher K
    Curr Atheroscler Rep; 2015 Jan; 17(1):471. PubMed ID: 25410047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.
    Wei MY; Ito MK; Cohen JD; Brinton EA; Jacobson TA
    J Clin Lipidol; 2013; 7(5):472-83. PubMed ID: 24079289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of statin adherence.
    Mauskop A; Borden WB
    Curr Cardiol Rep; 2011 Dec; 13(6):553-8. PubMed ID: 21947789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some causes of poor adherence to long-term statin therapy and their solution.
    Soška V; Kyselák O
    Vnitr Lek; 2018; 64(10):923-927. PubMed ID: 30590938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry.
    Bradley CK; Wang TY; Li S; Robinson JG; Roger VL; Goldberg AC; Virani SS; Louie MJ; Lee LV; Peterson ED; Navar AM
    J Am Heart Assoc; 2019 Apr; 8(7):e011765. PubMed ID: 30913959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review to assess adherence and persistence with statins.
    Deshpande S; Quek RG; Forbes CA; de Kock S; Kleijnen J; Gandra SR; Simpson RJ
    Curr Med Res Opin; 2017 Apr; 33(4):769-778. PubMed ID: 28076703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review.
    Simpson RJ; Mendys P
    J Clin Lipidol; 2010; 4(6):462-71. PubMed ID: 21122692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-adherence to statin therapy: a major challenge for preventive cardiology.
    Bates TR; Connaughton VM; Watts GF
    Expert Opin Pharmacother; 2009 Dec; 10(18):2973-85. PubMed ID: 19954271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin Adherence: Does Gender Matter?
    Goldstein KM; Zullig LL; Bastian LA; Bosworth HB
    Curr Atheroscler Rep; 2016 Nov; 18(11):63. PubMed ID: 27696318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin Intolerance: the Clinician's Perspective.
    Stulc T; Ceška R; Gotto AM
    Curr Atheroscler Rep; 2015 Dec; 17(12):69. PubMed ID: 26490078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statins with a perspective of lifelong therapy].
    Ertaş FS
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing statin adverse effects in the clinic: the 5 Ms.
    Katz DH; Intwala SS; Stone NJ
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):533-42. PubMed ID: 24770611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
    BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of statin-intolerant patient.
    Arca M; Pigna G; Favoccia C
    Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin drug interactions and related adverse reactions.
    Bellosta S; Corsini A
    Expert Opin Drug Saf; 2012 Nov; 11(6):933-46. PubMed ID: 22866966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially important considerations in choosing specific statin treatments to reduce overall morbidity and mortality.
    Lim S; Sakuma I; Quon MJ; Koh KK
    Int J Cardiol; 2013 Sep; 167(5):1696-702. PubMed ID: 23159411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming toxicity and side-effects of lipid-lowering therapies.
    Wilkinson MJ; Laffin LJ; Davidson MH
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):439-52. PubMed ID: 24840269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding patients' perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review.
    Chee YJ; Chan HH; Tan NC
    Singapore Med J; 2014 Aug; 55(8):416-21. PubMed ID: 25189302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When statin therapy stops: implications for the patient.
    Daskalopoulou SS
    Curr Opin Cardiol; 2009 Sep; 24(5):454-60. PubMed ID: 19574923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.